The Board affirmed refusals to register the mark MAGNESITA for refractory bricks and related products, on the ground of genericness, and for providing information via a global computer network regarding ...
By now, most patent practitioners have a fairly sophisticated understanding of the “new” (five year old) patent law, the Leahy Smith America Invent Act. Everyone knows that it is very ...
In Top Ten No. (7) Life Techs. Corp. v. Promega Corp., Supreme Court No. 14-1538, the Solicitor General has now filed his CVSG amicus brief. He recommends that the Court ...
Enfish, LLC v. Microsoft Corp., __ F.3d __ (Fed. Cir. May 12, 2016)(Hughes, J.), is a an important decision dealing with software patent-eligibility, but only because it is a rare ...
Stanford University Law School Professor Mark A. Lemley’s impressive amicus brief in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., Fed. Cir. 2016-1284, was noted earlier today, contrasted with the ...
The USPTO refused registration of the mark shown below for "financial analysis and consultation," deeming it to be a phantom mark - i.e., a mark with a changeable element - ...
Esteemed Stanford University Law School Professor Mark A. Lemley has produced an impressive amicusbrief in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., Fed. Cir. 2016-1284. Professor Lemley argues that ...
The U.S. Court of Appeals for the Federal Circuit affirmed the TTAB's ruling in In re Cordua Restaurants LP, 110 USPQ2d 1227 (TTAB 2014) [precedential] [TTABlogged here], finding the term ...
The previous note (attached) focuses on what's neither in the Rules of Practice in Patent Cases, the Manual of Patent Examining Procedure nor the mammoth AIPLA treatise cited in the ...
In the five years since the Leahy Smith America Invents Act became law, many Americans have adapted to the new reality of first-to-file. Yet, theRules of Practice in Patent Cases ...